200 related articles for article (PubMed ID: 22684020)
1. Regulatory role of KEAP1 and NRF2 in PPARγ expression and chemoresistance in human non-small-cell lung carcinoma cells.
Zhan L; Zhang H; Zhang Q; Woods CG; Chen Y; Xue P; Dong J; Tokar EJ; Xu Y; Hou Y; Fu J; Yarborough K; Wang A; Qu W; Waalkes MP; Andersen ME; Pi J
Free Radic Biol Med; 2012 Aug; 53(4):758-68. PubMed ID: 22684020
[TBL] [Abstract][Full Text] [Related]
2. Cross-regulations among NRFs and KEAP1 and effects of their silencing on arsenic-induced antioxidant response and cytotoxicity in human keratinocytes.
Zhao R; Hou Y; Zhang Q; Woods CG; Xue P; Fu J; Yarborough K; Guan D; Andersen ME; Pi J
Environ Health Perspect; 2012 Apr; 120(4):583-9. PubMed ID: 22476201
[TBL] [Abstract][Full Text] [Related]
3. T Cell
Kurzhagen JT; Noel S; Lee K; Sadasivam M; Gharaie S; Ankireddy A; Lee SA; Newman-Rivera A; Gong J; Arend LJ; Hamad ARA; Reddy SP; Rabb H
Antioxid Redox Signal; 2023 May; 38(13-15):959-973. PubMed ID: 36734409
[No Abstract] [Full Text] [Related]
4. Haem oxygenase-1 up-regulation by rosiglitazone via ROS-dependent Nrf2-antioxidant response elements axis or PPARγ attenuates LPS-mediated lung inflammation.
Cho RL; Yang CC; Tseng HC; Hsiao LD; Lin CC; Yang CM
Br J Pharmacol; 2018 Oct; 175(20):3928-3946. PubMed ID: 30088830
[TBL] [Abstract][Full Text] [Related]
5. The cytoprotective role of the Keap1-Nrf2 pathway.
Baird L; Dinkova-Kostova AT
Arch Toxicol; 2011 Apr; 85(4):241-72. PubMed ID: 21365312
[TBL] [Abstract][Full Text] [Related]
6. KEAP1 gene mutations and NRF2 activation are common in pulmonary papillary adenocarcinoma.
Li QK; Singh A; Biswal S; Askin F; Gabrielson E
J Hum Genet; 2011 Mar; 56(3):230-4. PubMed ID: 21248763
[TBL] [Abstract][Full Text] [Related]
7. Nrf2 depletion in the context of loss-of-function Keap1 leads to mitolysosome accumulation.
Dayalan Naidu S; Angelova PR; Knatko EV; Leonardi C; Novak M; de la Vega L; Ganley IG; Abramov AY; Dinkova-Kostova AT
Free Radic Biol Med; 2023 Nov; 208():478-493. PubMed ID: 37714439
[TBL] [Abstract][Full Text] [Related]
8. Nrf2-dependent and -independent responses to nitro-fatty acids in human endothelial cells: identification of heat shock response as the major pathway activated by nitro-oleic acid.
Kansanen E; Jyrkkänen HK; Volger OL; Leinonen H; Kivelä AM; Häkkinen SK; Woodcock SR; Schopfer FJ; Horrevoets AJ; Ylä-Herttuala S; Freeman BA; Levonen AL
J Biol Chem; 2009 Nov; 284(48):33233-41. PubMed ID: 19808663
[TBL] [Abstract][Full Text] [Related]
9. High CD44 expression mediates p62-associated NFE2L2/NRF2 activation in breast cancer stem cell-like cells: Implications for cancer stem cell resistance.
Ryoo IG; Choi BH; Ku SK; Kwak MK
Redox Biol; 2018 Jul; 17():246-258. PubMed ID: 29729523
[TBL] [Abstract][Full Text] [Related]
10. Targeting NFE2L2/KEAP1 Mutations in Advanced NSCLC With the TORC1/2 Inhibitor TAK-228.
Paik PK; Fan PD; Qeriqi B; Namakydoust A; Daly B; Ahn L; Kim R; Plodkowski A; Ni A; Chang J; Fanaroff R; Ladanyi M; de Stanchina E; Rudin CM
J Thorac Oncol; 2023 Apr; 18(4):516-526. PubMed ID: 36240971
[TBL] [Abstract][Full Text] [Related]
11. Non-electrophilic modulators of the canonical Keap1/Nrf2 pathway.
Richardson BG; Jain AD; Speltz TE; Moore TW
Bioorg Med Chem Lett; 2015 Jun; 25(11):2261-8. PubMed ID: 25937010
[TBL] [Abstract][Full Text] [Related]
12. Natural products as non-covalent and covalent modulators of the KEAP1/NRF2 pathway exerting antioxidant effects.
Culletta G; Buttari B; Arese M; Brogi S; Almerico AM; Saso L; Tutone M
Eur J Med Chem; 2024 Apr; 270():116355. PubMed ID: 38555855
[TBL] [Abstract][Full Text] [Related]
13. Dietary regulation of Keap1/Nrf2/ARE pathway: focus on plant-derived compounds and trace minerals.
Stefanson AL; Bakovic M
Nutrients; 2014 Sep; 6(9):3777-801. PubMed ID: 25244368
[TBL] [Abstract][Full Text] [Related]
14.
Occhiuto CJ; Liby KT
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542481
[TBL] [Abstract][Full Text] [Related]
15. An exceptionally potent inducer of cytoprotective enzymes: elucidation of the structural features that determine inducer potency and reactivity with Keap1.
Dinkova-Kostova AT; Talalay P; Sharkey J; Zhang Y; Holtzclaw WD; Wang XJ; David E; Schiavoni KH; Finlayson S; Mierke DF; Honda T
J Biol Chem; 2010 Oct; 285(44):33747-55. PubMed ID: 20801881
[TBL] [Abstract][Full Text] [Related]
16. "Keaping" a lid on lung cancer: the Keap1-Nrf2 pathway.
Best SA; Sutherland KD
Cell Cycle; 2018; 17(14):1696-1707. PubMed ID: 30009666
[TBL] [Abstract][Full Text] [Related]
17. CPT1B maintains redox homeostasis and inhibits ferroptosis to induce gemcitabine resistance via the KEAP1/NRF2 axis in pancreatic cancer.
Tuerhong A; Xu J; Wang W; Shi S; Meng Q; Hua J; Liu J; Zhang B; Yu X; Liang C
Surgery; 2024 May; 175(5):1264-1275. PubMed ID: 38302326
[TBL] [Abstract][Full Text] [Related]
18. Glycosylation of KEAP1 links nutrient sensing to redox stress signaling.
Chen PH; Smith TJ; Wu J; Siesser PF; Bisnett BJ; Khan F; Hogue M; Soderblom E; Tang F; Marks JR; Major MB; Swarts BM; Boyce M; Chi JT
EMBO J; 2017 Aug; 36(15):2233-2250. PubMed ID: 28663241
[TBL] [Abstract][Full Text] [Related]
19. AURKA emerges as a vulnerable target for KEAP1-deficient non-small cell lung cancer by activation of asparagine synthesis.
Deng B; Liu F; Chen N; Li X; Lei J; Chen N; Wu J; Wang X; Lu J; Fang M; Chen A; Zhang Z; He B; Yan M; Zhang Y; Wang Z; Liu Q
Cell Death Dis; 2024 Mar; 15(3):233. PubMed ID: 38521813
[TBL] [Abstract][Full Text] [Related]
20. An antioxidant feedforward cycle coordinated by linker histone variant H1.2 and NRF2 that drives nonsmall cell lung cancer progression.
Chen Y; Shi J; Wang X; Zhou L; Wang Q; Xie Y; Peng C; Kuang L; Yang D; Yang J; Yang C; Li X; Yuan Y; Zhou Y; Peng A; Zhang Y; Chen H; Liu X; Zheng L; Huang K; Li Y
Proc Natl Acad Sci U S A; 2023 Sep; 120(39):e2306288120. PubMed ID: 37729198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
